#  @fumi238pochi 🇺🇸Stock AnalystT+0🔥🔥🔥 🇺🇸Stock AnalystT+0🔥🔥🔥 posts on X about strong, target, ai, acquisition the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::2597587381/interactions)  - [--] Week [-----] -33% - [--] Month [-----] +9.80% - [--] Months [------] +860% ### Mentions: [--] [#](/creator/twitter::2597587381/posts_active)  - [--] Month [--] -27% - [--] Months [---] +641% ### Followers: [---] [#](/creator/twitter::2597587381/followers)  - [--] Week [---] +1.20% - [--] Month [---] +6.80% - [--] Months [---] +443% ### CreatorRank: [---------] [#](/creator/twitter::2597587381/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) 43% [stocks](/list/stocks) 38% [technology brands](/list/technology-brands) 15% [cryptocurrencies](/list/cryptocurrencies) 14% [exchanges](/list/exchanges) 8% [automotive brands](/list/automotive-brands) 7% [countries](/list/countries) 2% [agencies](/list/agencies) 2% [currencies](/list/currencies) 1% [travel destinations](/list/travel-destinations) 1% **Social topic influence** [strong](/topic/strong) 27%, [target](/topic/target) 25%, [ai](/topic/ai) 16%, [acquisition](/topic/acquisition) 9%, [beat](/topic/beat) 8%, [products](/topic/products) 7%, [company](/topic/company) 7%, [nasdaq](/topic/nasdaq) 7%, [momentum](/topic/momentum) 6%, [dividend](/topic/dividend) 6% **Top assets mentioned** [NVIDIA Corp. (NVDA)](/topic/$nvda) [Tesla, Inc. (TSLA)](/topic/$tsla) [Sandisk Corporation (SNDK)](/topic/$sndk) [Micron Technology, Inc. (MU)](/topic/$mu) [Metadium (META)](/topic/$meta) [Sanofi (SNY)](/topic/sanofi) [Engines of Fury (FURY)](/topic/$fury) [Sable Offshore Corp. (SOC)](/topic/$soc) [Sidus Space, Inc. (SIDU)](/topic/$sidu) [Context Therapeutics Inc. (CNTX)](/topic/$cntx) [Intel Corporation (INTC)](/topic/$intc) [Taiwan Semiconductor (TSM)](/topic/$tsm) [Direct Digital Holdings, Inc. (DRCT)](/topic/$drct) [ARB IOT Group Limited (ARBB)](/topic/$arbb) [Banco Bradesco S.A. American Depositary Shares (BBDO)](/topic/$bbdo) [ZetaChain (ZETA)](/topic/$zeta) [Lumentum Holdings Inc. Common Stock (LITE)](/topic/$lite) [Ocular Therapeutix, Inc. (OCUL)](/topic/$ocul) [Robinhood Markets, Inc. (HOOD)](/topic/$hood) [CCH Holdings Ltd (CCHH)](/topic/$cchh) [Validity (VAL)](/topic/$val) [Medtronic PLC (MDT)](/topic/medtronic) [Anteris Technologies Global Corp. (AVR)](/topic/$avr) ### Top Social Posts Top posts by engagements in the last [--] hours "$LITE AI data center leader; photonics innovation; sold-out lasers; resilient operations. Q2 FY26 earnings beat; strong guidance; analyst upgrades/PT raises. Today's Rise: Up 8.45%; earnings momentum; AI demand; optimistic upgrades" [X Link](https://x.com/fumi238pochi/status/2019770899419840841) 2026-02-06T13:51Z [---] followers, [---] engagements "$OCUL Ocular Therapeutix (OCUL) eye disease biotech with sustained-release tech. Advantages: Patented platform; AXPAXLI pipeline; $345M cash to 2028; 58% growth forecast. Recent News: Sanofi rumors; trials; Q3 revenue $14.5M. Rise Cause: Up 21.32% on Sanofi acquisition buzz" [X Link](https://x.com/fumi238pochi/status/2011768256345096245) 2026-01-15T11:51Z [---] followers, [---] engagements "$HOOD Leading commission-free brokerage user-friendly app. Recent News: Q4 EPS est. $0.63 revenue +30%. Advantages: Diversified products crypto integration. Stock Rise: +6.32% on crypto rebound & market recovery" [X Link](https://x.com/fumi238pochi/status/2019774583499378726) 2026-02-06T14:06Z [---] followers, [---] engagements "$NBY Shift to digital assets; $134M funding; ATM issuance caused 54% drop; auditor change; shareholder meeting March [--]. Innovative eye/wound products; strong team; pivot potential; extended cash runway to [----]. Today's Rise: Speculative rebound from lows; oversold RSI" [X Link](https://x.com/fumi238pochi/status/2020840011084751251) 2026-02-09T12:39Z [---] followers, [---] engagements "$POWW Q3 earnings beat (EPS $0.01 revenue +7%); GunBroker integration; $15M buyback; SEC settlement. Leading gun marketplace; high margins (86.9%); strong cash ($69M); innovation in ammo/tech. Earnings surprise; operational gains; positive sentiment; potential 41% upside" [X Link](https://x.com/fumi238pochi/status/2020841247737569423) 2026-02-09T12:44Z [---] followers, [---] engagements "$BRLS Todays Surge: $BRLS up 100.61% with high volume breakout. Key Driver: Speculative rebound insider buying signals. Company Strengths: 45% sales growth expanding distribution premium brand awards. Outlook: watch financing updates. $UOKA $BRLS $CCHH $CCHH $VAL $EZRA" [X Link](https://x.com/fumi238pochi/status/2020888224575467911) 2026-02-09T15:51Z [---] followers, [---] engagements "🔥Consistent US stock profits 🔥Stop trading blind get direction + real-time strategies + key levels. 🔥Catch real opportunities. Avoid dumb losses. 🔥Click Join: 🔥Join our WhatsApp group Remove guesswork and trade profitably. http://wa.me/16469198509 http://wa.me/16469198509" [X Link](https://x.com/fumi238pochi/status/2021009687186112554) 2026-02-09T23:53Z [---] followers, [---] engagements "Today's recommended high-quality stocks will be shared in detail with buy and sell strategies in my WhatsApp group. Stock enthusiasts can add me on WhatsApp: 👇 👇 Reply "stocks" after adding to join. Don't miss any opportunity to grow your wealth. http://wa.me/16469198509 http://wa.me/16469198509" [X Link](https://x.com/fumi238pochi/status/2021225077447041475) 2026-02-10T14:09Z [---] followers, [---] engagements "$FURY Advantages: $20M cash Dolly Varden stake experienced board (Baker) Eau Claire NPV $554M sustainable ops. Jan 26: Appointed Baker; Jan 8: [----] review [----] drills. Jan [--] Rise (11.64%): Baker hire gold $5K/oz HC Wainwright $1.40 buy" [X Link](https://x.com/fumi238pochi/status/2016850920412262401) 2026-01-29T12:28Z [---] followers, [---] engagements "$TLF US leather craft retailer with stores and online sales. Strengths: Diverse products; strong cash flow; educational resources. News: $0.75/share special dividend; Q3 [----] earnings; asset sales. Rise Today: Dividend announcement boosted 16.52% pre-market to $3.35" [X Link](https://x.com/fumi238pochi/status/2019026579029201364) 2026-02-04T12:33Z [---] followers, [---] engagements "$AVR Company: Anteris Tech (AVR): Structural heart devices. Advantages: Innovative valves clinical data Medtronic ties. News: $20M offering; Medtronic $90M investment. Rise: Financing sparked 8.52% surge" [X Link](https://x.com/fumi238pochi/status/2013960494076273045) 2026-01-21T13:02Z [---] followers, [---] engagements "$LIMN Innovative CD47 antibodies for immuno-oncology GCC vaccine in Phase II strategic financing via equity and crypto. $30M equity MOU; digital asset investments. Today's Rise: Up 22.10% to $0.6973 on compliance speculation crypto strategies and momentum trading" [X Link](https://x.com/fumi238pochi/status/2018705223141773536) 2026-02-03T15:16Z [---] followers, [---] engagements "$LIMN surged 33.18% to $1.43 Congrats to those who bought $LIMN yesterday pocketed $1200-2800profit $LIMN Innovative CD47 antibodies for immuno-oncology GCC vaccine in Phase II strategic financing via equity and crypto. $30M equity MOU; digital asset investments. Today's Rise: Up 22.10% to $0.6973 on compliance speculation crypto strategies and momentum trading. https://t.co/xZ9R2LgKgL $LIMN Innovative CD47 antibodies for immuno-oncology GCC vaccine in Phase II strategic financing via equity and crypto. $30M equity MOU; digital asset investments. Today's Rise: Up 22.10% to $0.6973 on" [X Link](https://x.com/fumi238pochi/status/2019101739765624985) 2026-02-04T17:32Z [---] followers, [---] engagements "$GDTC News: Rejected misleading claims; MoU with UMMC; Acquired TC BioPharm tech; Chair stake up 21.95%. Strengths: Patented T cells; Strong pipeline; Clinical progress; Partnerships; Debt-free. Rise: Rebuttal drove 27.07% pre-market surge; High volume squeeze" [X Link](https://x.com/fumi238pochi/status/2019400502539350225) 2026-02-05T13:19Z [---] followers, [---] engagements "$ALGN News: Q4 revenue/EPS beat; Q1/FY guidance up; Swiss/Canadian initiatives. Strengths: Invisalign leader; AI/3D tech; Global dentists; High margins. Rise: Earnings/guidance drove 10.35% pre-market surge" [X Link](https://x.com/anyuser/status/2019404434221023457) 2026-02-05T13:35Z [---] followers, [---] engagements "$PAHC surged after Q2 FY2026 earnings beat. EPS $0.87 vs $0.69 est.; revenue $373.9M vs $355.6M. Raised FY2026 EPS guidance to $2.93$3.10 (above $2.75 consensus). Driven by strong MFA portfolio 10.1% operating margin & positive animal health outlook" [X Link](https://x.com/fumi238pochi/status/2019415087468146710) 2026-02-05T14:17Z [---] followers, [---] engagements "$EHC Largest US inpatient rehab operator scale & innovation advantages. Q4 [----] Earnings: Revenue +10.5% to $1.54B EPS $1.46 (beat estimates). [----] Guidance: Revenue $6.37-6.47B EPS $5.81-6.10. Stock Rise: +18.54% due to strong results & outlook" [X Link](https://x.com/fumi238pochi/status/2019765409939968019) 2026-02-06T13:29Z [---] followers, [---] engagements "$ABP DiversImmune & MultiMab platforms for antibodies; leads ABP-102 (HER2/CD3) ABP-201 (VEGF/ANG-2). Celltrion partnerships; pipeline in immuno-oncology/ophthalmology. Strong IP in multispecifics for HER2+ cancers HCC gastric" [X Link](https://x.com/anyuser/status/2021206365243572476) 2026-02-10T12:55Z [---] followers, [---] engagements "$CRDO Q3 FY2026 revenue $404-408M (beat guidance); FY2026 growth 200%; Needham Buy rating $220 target; new Blue Heron retimer launched. Today's Rise: Up 13.78% pre-market to $140 on earnings beat AI demand surge analyst upgrades; Q3 51.5% sequential growth fuels optimism" [X Link](https://x.com/fumi238pochi/status/2021214160831357020) 2026-02-10T13:26Z [---] followers, [---] engagements "$RENX Zimmer contract win debt restructure Nasdaq compliance notice equipment acquisitions. Sustainable waste-to-value tech licensing diversified eco-products financial growth. New Florida transport contract announcement pre-market surge 128.07%" [X Link](https://x.com/fumi238pochi/status/2021561678840963515) 2026-02-11T12:27Z [---] followers, [---] engagements "$NET Recent News: Q4 revenue $614.5M (up 34%) full-year $2.17B (up 33%) AI acquisitions analyst upgrades. Strengths: Global network zero-trust security CDN optimization AI integration revenue growth. Rise Cause: Strong Q4 earnings beat AI tailwinds; up 14.77%" [X Link](https://x.com/fumi238pochi/status/2021564507877937158) 2026-02-11T12:38Z [---] followers, [---] engagements "$LUXE Company: Global luxury group e-commerce retail via YNAP. Strengths: E-com scale unique experiences sales growth 5.7%. Recent News: Q2 sales 647M (tripled) EBITDA positive. Rise Today: +7.04% to $10.65 on JPM upgrade Q2 optimism" [X Link](https://x.com/fumi238pochi/status/2021916162389401934) 2026-02-12T11:55Z [---] followers, [---] engagements "$ATNI News: Sold towers for $297M; Q3 '25 EPS $0.18 beat; dividend. Strengths: Niche markets; fiber growth; $97M cash low debt. Rise Today: Tower sale drove 19.71% surge; debt reduction" [X Link](https://x.com/anyuser/status/2021933371731894288) 2026-02-12T13:04Z [---] followers, [---] engagements "$MU Company: Semiconductor leader in DRAM NAND HBM for AI/data centers. Strengths: Tech lead in nodes 25% HBM share high margins 57-68%. Recent News: HBM4 early shipment; Q1 revenue $13.6B (+57%). Rise Today: +4.15% to $424.72 on HBM supply tightness AI demand" [X Link](https://x.com/fumi238pochi/status/2021937059028713478) 2026-02-12T13:18Z [---] followers, [---] engagements "$NRXP Recent News: Cleared $5.4M debt via equity Q3 report highlights NRX-101 progress FDA designations. Strengths: CNS focus on bipolar depression/PTSD; 70+ patents; HOPE subsidiary for clinics. Today's : Debt elimination boosts investor confidence stock up from $1.99 low" [X Link](https://x.com/fumi238pochi/status/2001646108536340595) 2025-12-18T13:29Z [---] followers, [---] engagements "$SOC Recent News: PHMSA pipeline interstate confirmation; Q3 savings; [----] Santa Ynez restart. Strengths: Offshore oil/gas; proven reserves 100+ wells; $17/bbl costs; expert team. Today's Rise: Regulatory fix ends CA hurdles; confidence surge; up 43-68% from $5.28" [X Link](https://x.com/fumi238pochi/status/2001649361122660431) 2025-12-18T13:42Z [---] followers, [---] engagements "$NBY Recent News: Special dividend $0.80/share; Zacks buy rating; CEO change; stock volatile. Strengths: Innovative eye/skin products; market penetration; strategic funding. Today's Rise: +30% on Zacks upgrade dividend reminder. $ORCL $CRWV $VLRS $SMX $BMRN $LUNR $BENF $LAZR" [X Link](https://x.com/fumi238pochi/status/2002046548486852675) 2025-12-19T16:01Z [---] followers, [---] engagements "$VMAR Recent News: $9.6M offering completed Dec 19; volatile stock 160% surge Dec 16; boat show promo. Strengths: Electric boat leader; zero-emission E-Motion tech; diverse models. Today's Rise: +29.4% on financing rebound short squeeze speculation. $HYMC $WKEY $THAR $MSN" [X Link](https://x.com/fumi238pochi/status/2003056463590428849) 2025-12-22T10:54Z [---] followers, [---] engagements "$THAR Recent:$1.85M compliance Sep 5; TH104 update Aug (+7%); $1.74M offering Jul; 240% surge Aug; CEO buy Dec [--]. Strengths:Immunology innovator; TH104 for itch; Minotaur partners; strong cash; FDA/EMA feedback. Today's:+12% on CEO buy clinical rebounds social buzz/squeeze" [X Link](https://x.com/fumi238pochi/status/2003059184536088919) 2025-12-22T11:04Z [---] followers, [---] engagements "$BMRA Strengths: GI diagnostics; innovative inFoods IBS test; cost-reducing solutions. Recent News: CMS $300 rate; Egypt auth; Q1 earnings; meeting approvals. Today's Surge: +5-10% on Medicare rate; boosts access; low float hype" [X Link](https://x.com/fumi238pochi/status/2003469114388676676) 2025-12-23T14:13Z [---] followers, [--] engagements "$METC Target Price: $34.50 Advantages: Premium met coal ops + rare earth/critical minerals transition (Brook Mine); strong liquidity from recent capital raises Today: Up 5.9% to $16.89 ; driven by $100M buyback announcement + technical rebound (double bottom RSI bullish)" [X Link](https://x.com/fumi238pochi/status/2003779233555050945) 2025-12-24T10:46Z [---] followers, [--] engagements "$INDP Target Price:$10.20-$10.50 Recent News: Lazar appointed co-CEO after stake buy; Q3 R&D costs down; Decoy20 clinical updates & $5.7M funding. Rise Reasons: Lazar's investment sparks 64% surge; low float amplifies volatility; positive sentiment on leadership. $MWG $DVAX" [X Link](https://x.com/fumi238pochi/status/2003802113659617398) 2025-12-24T12:17Z [---] followers, [---] engagements "$PATH Target Price: $19.00 Innovation leader (TIME Best 2025); network effects; FY25 rev $1.43B (+9%); 9% CAGR to [----]. Advantages: Joins S&P MidCap [---] Jan 2; insider sales; strong [----] performance. Recent News: S&P inclusion sparked 8.46% pre-market; long-term positive" [X Link](https://x.com/fumi238pochi/status/2003820112395346076) 2025-12-24T13:28Z [---] followers, [--] engagements "$SIDU Target price:$10-$20 Advantages: Full-stack space tech cost-effective solutions Florida hub defense contracts growth potential. Recent News: SHIELD program entry $25M public offering. Rise Cause: +30% on offering completion boosting finances. $IREN $BMNR $SOAR $FLYX" [X Link](https://x.com/fumi238pochi/status/2004538916146397358) 2025-12-26T13:04Z [---] followers, [---] engagements "$FLYX Target price:$4.67-$4.75 Advantages: Jet charters 20% Q3 revenue growth fleet efficiency aviation trends. Recent News: Volato FLYX dividend Mobile Service expansion Q3 earnings. Rise Cause: +5% on dividend record date momentum. $NCL $SOAR $CANF $SCNI $ATPC $SPRC" [X Link](https://x.com/fumi238pochi/status/2004555779110801412) 2025-12-26T14:11Z [---] followers, [--] engagements "$MEHA Strengths: Real revenue Amazon/Walmart sales new Kirkman beauty line. News: Strong Q3 new beauty launch post-IPO rebound. Todays Rise: Beauty momentum + seasonal demand + micro-cap speculation. Price: Rebound from $0.22 short-term target $0.50$1.00" [X Link](https://x.com/fumi238pochi/status/2004574217791262770) 2025-12-26T15:25Z [---] followers, [---] engagements "$VNDA Targets: $11.75-$14 Q3 sales up 18% to $56M; FDA lifts clinical hold Dec 4; Tradipitant positive data Nov 19; PDUFA for motion sickness Dec [--]. CNS-focused biopharma; key products Fanapt Hetlioz Ponvory; strong pipeline in rare diseases; solid cash for R&D" [X Link](https://x.com/fumi238pochi/status/2005627304521912460) 2025-12-29T13:09Z [---] followers, [---] engagements "$ESHA ESHA SPAC targets entertainment sports hospitality; merging with TOFF for health/fitness focus. Experienced team global network $5B+ value created. Recent News: Merger progress; deadline extended to Dec [----]. Today's Rise: +50.66% on merger optimism high volume" [X Link](https://x.com/fumi238pochi/status/2006348729222361572) 2025-12-31T12:56Z [---] followers, [---] engagements "$SOC High asset rights oil field growth potential $773M funding strong analyst buys (targets $19-33). Pipeline permit court denies injunction stock up 15% in Dec Roth MKM buy rating. Today's Rise:Legal win momentum analyst optimism technical rebound energy sector buzz" [X Link](https://x.com/fumi238pochi/status/2007035140275675564) 2026-01-02T10:24Z [---] followers, [---] engagements "$GWH Supports AI data centers with 22-hr storage scalability. Q3 [----] rev $214K net loss $10.38M; [--] MWh SRP project $40M raised. "Strong Buy" rating $3.50 target. Today's Rise: +7.98% to $2.03 on analyst optimism investor day sector momentum. $DVLT $ULY $CHOW $SLS" [X Link](https://x.com/fumi238pochi/status/2007038935319679399) 2026-01-02T10:39Z [---] followers, [---] engagements "$ORBS Holds 277M WLD 11K ETH $69M cash. $125M buyback announced. Volatile down 8% last week. Crypto/digital ID shift; 59% rev growth. Low P/S 0.8; institutional support. Infinity platform differentiates. 20.33% surge Jan [--]. Speculation buyback hype. Market sentiment shift" [X Link](https://x.com/fumi238pochi/status/2008154919577010559) 2026-01-05T12:33Z [---] followers, [--] engagements "$CNTX Strengths: Strong pipeline (CTIM-76 CT-95) no debt "strong buy" rating oncology focus. Recent News: CTIM-76 Phase [--] dosing; Q3 [----] updates; small-cap potential. Today's Rise: +22.58% from technical breakout healthcare momentum analyst optimism. Targets: $5.67" [X Link](https://x.com/fumi238pochi/status/2008159134256934934) 2026-01-05T12:50Z [---] followers, [---] engagements "$NCPL Targets: $2.25-$3.25 Recent News: Acquired Iverson Design AI assets (Jan [--] 2026); Q2 earnings call (Jan 7). Strengths: Scalable fintech platform for private funding; AI integration; positive financing. Today's Rise: Driven by AI acquisition; up 27% after-hours" [X Link](https://x.com/fumi238pochi/status/2008860534805004448) 2026-01-07T11:17Z [---] followers, [--] engagements "$GLUE Strengths: AI-driven molecular glue degraders diverse pipeline (oncology immunology) Novartis partnership. Recent News: MRT-8102 Phase [--] data (Jan 7): CRP down 85% IL-6 down 55%; Novartis deal (Sep 2025). Today's Rise: Positive Phase [--] results drove 53.15% surge" [X Link](https://x.com/fumi238pochi/status/2008884250922328336) 2026-01-07T12:51Z [---] followers, [---] engagements "$NGEN Targets: $7.85-$8.0 NervGen Pharma (TSXV: NGEN) biotech focused on neural repair via PTP tech. Innovative NVG-291 for SCI; strong clinical progress; diverse pipeline; solid financing. Recent News: Positive Phase 1b/2a data; $10M raise; SEC filing for NASDAQ uplist" [X Link](https://x.com/fumi238pochi/status/2009217713298907431) 2026-01-08T10:56Z [---] followers, [----] engagements "$SER Advantages: Non-immunogenic POZ tech; SER-252 for Parkinson's; partnerships (Enable); regulatory fast-track. Recent News: Enable's $30M Sanofi investment; FDA hold response; $20M financing. Today's Rise:Up 12.4% on partner funding hype and trial optimism. $NVVE $ELAB $ACON" [X Link](https://x.com/fumi238pochi/status/2009238293188366466) 2026-01-08T12:18Z [---] followers, [---] engagements "$OPAD Target Price: $2.30-$3.68 Company Advantages: Fast cash home offers cost efficiency tech-driven valuations. Recent News: Q3 earnings improvement new CMO exec stock grants. Today's Rise: +34.21% from Trump's $200B mortgage bond plan stimulating housing demand" [X Link](https://x.com/fumi238pochi/status/2009614442246590653) 2026-01-09T13:13Z [---] followers, [--] engagements "$LDI Target Price: $2.63-$3.55 Recent News: Trump $200B bond buy to cut rates; Q3 rev up amid policy volatility. Top non-bank lender with digital origination; diversified services ($116B+ value). Today's Surge: +14.34% pre-market on Trump plan boosting housing/loan demand" [X Link](https://x.com/fumi238pochi/status/2009620977945022917) 2026-01-09T13:39Z [---] followers, [---] engagements "$SGN Company: Signing Day Sports sports recruitment tech platform. Strengths: Digital ecosystem mergers (Swifty BlockchAIn) 45% retention. Recent News: Q2 revenue down 67% events merger progress. Today's Rise: +21.90% from market rally technical rebound high volume" [X Link](https://x.com/fumi238pochi/status/2010692718435901739) 2026-01-12T12:37Z [---] followers, [--] engagements "$PMAX News: Jan [--] shareholder meeting for capital restructure; Q3 [----] revenue down; Nasdaq compliance issues. Strengths: Niche compliance services integrated model Hong Kong hub advantage. Rise Today: Up 44.44% on restructure announcement high volume; speculative rebound" [X Link](https://x.com/fumi238pochi/status/2011039273408217334) 2026-01-13T11:35Z [---] followers, [---] engagements "$KELYA Recent News: Adopted poison pill for B-class shares sale ($1.06B); analyst target $17.67 (+95%). Strengths: Global staffing leader; diverse services; strong brand; low valuation growth. Today's Rise: Poison pill catalyst; technical breakout; +17.99% post-market" [X Link](https://x.com/fumi238pochi/status/2011043032905212337) 2026-01-13T11:49Z [---] followers, [--] engagements "$SAFX Recent News: Financing options explored; MOU with IP3 Southern for nuclear SAF; capacity doubling at Reno. Modular scalable SAF facilities; full-chain platform; IP licensing; ESG leadership. Today: Debt-to-equity conversion ($28M); BofA financing boost; volume surge" [X Link](https://x.com/fumi238pochi/status/2011393855896310208) 2026-01-14T11:03Z [---] followers, [---] engagements "$MREO Recent News: Target cuts (Needham $3); setrusumab analysis; alvelestat Phase 3; Phase [--] failure. Strengths: Rare disease focus; debt-free cash to 2027; partnerships; valuation appeal. Today's Rise: Update momentum; analyst buy; JPM event; volume surge. $MREO Company Advantages: Rare diseases pipeline efficient capital model debt-free with cash runway to [----]. Recent News: Phase [--] missed primary endpoint; Q3 loss; CEO at JPM conference. Stock Rise: Up 9.99% on Jan [--] from conference announcement. https://t.co/snq6KAAMF9 $MREO Company Advantages: Rare diseases pipeline efficient capital" [X Link](https://x.com/fumi238pochi/status/2011397572100067351) 2026-01-14T11:18Z [---] followers, [---] engagements "$NINE Recent News: Q3 [----] revenue $132M net loss $14.6M; Q4 forecast $122-132M. Advantages: ROCE 4.4%; intl revenue +19%; operational flexibility. Rise Cause: Up 13.48% amid oil price surge energy sector rally. $COIN $INTC $MSTR $FURY $DRTS $SEGG $IVP $ALTS $BARK $BNAI $NINE" [X Link](https://x.com/fumi238pochi/status/2011465194157801806) 2026-01-14T15:47Z [---] followers, [---] engagements "$RILY Company: BRC Group Holdings (RILY) diversified financial services. Advantages:Integrated banking/brokerage; mid-market expertise; flexible structure. Recent News:Q3 profit $91M; Nasdaq compliance; name change. Rise Cause: Up 38% on Q3 earnings beat delisting avoidance" [X Link](https://x.com/fumi238pochi/status/2011764057335087124) 2026-01-15T11:35Z [---] followers, [---] engagements "$BNKK Company: Bonk Inc. (BNKK) digital assets in BONK ecosystem. Advantages: revenue; Yerba brand; 100% growth forecast. Recent News: TenX partnership; Q1 $1.5M income; debt zero. Rise Cause: Up 49.64% on TenX BONK deal. $NVDA $TSM $TSLA $SNDK $CJMB http://BONK.fun http://BONK.fun" [X Link](https://x.com/fumi238pochi/status/2011812728311087330) 2026-01-15T14:48Z [---] followers, [--] engagements "$BYAH Recent News: Capital increase approval reverse split ticker change to BYAH. Strengths: Bio-skincare products restructuring for compliance low valuation. Today's Minor Uptick: Market factors post-restructuring sentiment penny volatility" [X Link](https://x.com/fumi238pochi/status/2012133164844741067) 2026-01-16T12:01Z [---] followers, [--] engagements "$SVRE Strengths:Anti-distraction system VRU detection partnerships (Cemex FedEx) patents TIME [----] Invention. Recent News:VisionWave LOI for RF defense US distribution deals 1:3 ADS split H1 [----] revenue up 57%. Today's Surge:+48.6% to $2.18 VisionWave deal 14.6M vol" [X Link](https://x.com/fumi238pochi/status/2012135557149995415) 2026-01-16T12:11Z [---] followers, [---] engagements "$SNDK Recent News: Analyst upgrades (450-580 targets) NVIDIA AI comments Q4 beat 52-week high. Strengths: NAND leader AI demand pricing power high EPS growth. Today's 5.21% Rise: Sector rally ( $TSM $MU) analyst optimism momentum" [X Link](https://x.com/fumi238pochi/status/2012138792631803962) 2026-01-16T12:24Z [---] followers, [---] engagements "$SHPH Company: Shuttle Pharma (SHPH): Cancer radiation sensitizers. Advantages: Innovative therapies AI discovery low valuation ($4M). News: acquisition; Phase [--] trials; funding. Rise: AI news drove 160.74% surge high volume. http://Molecule.ai http://Molecule.ai" [X Link](https://x.com/fumi238pochi/status/2013614522934890896) 2026-01-20T14:08Z [---] followers, [--] engagements "$RAPT Company: RAPT Therapeutics ( $RAPT): Immunology therapies for allergies. Advantages: Innovative antibodies clinical progress high potential. News: GSK $2.2B acquisition; Phase II trials. Rise: Acquisition news sparked 63.68% surge" [X Link](https://x.com/fumi238pochi/status/2013616225117708649) 2026-01-20T14:14Z [---] followers, [--] engagements "$UNG Company: UNG: ETF tracking natural gas futures. Advantages: Easy exposure high liquidity short-term trading. News: Futures rebound; weather LNG demand. Rise: Storm forecasts sparked 8%-20.14% surge" [X Link](https://x.com/fumi238pochi/status/2013618043616928078) 2026-01-20T14:22Z [---] followers, [--] engagements "$IMTE Strengths: Diverse: smart glass NFT platform halal cert; low-float. News: Nasdaq delist notices; filing delays. Surge: Low-float squeeze; compliance buzz; +64.03% pre-market" [X Link](https://x.com/fumi238pochi/status/2013955502183432413) 2026-01-21T12:43Z [---] followers, [--] engagements "$SXTP Recent News: 1:4 split Jan 20; Q3 sales +223%; Babesia study; ARAKODA growth. Company Strengths: FDA ARAKODA; innovation partners; clinical pipeline; "Strong Buy" $4.40 target. Today's Rise: +78% to $3.56 pre-market; split momentum; volume 247K; speculation" [X Link](https://x.com/fumi238pochi/status/2014322032700539369) 2026-01-22T12:59Z [---] followers, [--] engagements "$CUE Recent News: Insider buys; $10M offering; Q3 EPS beat; ImmunoScape deal; CUE-101 50% ORR. Company Strengths: Immuno-STAT; pipeline (CUE-101/102/401); partnerships; $5.10 target. Today's Rise: +7.64% to $0.4044 pre-market; biotech surge; high volume; speculation" [X Link](https://x.com/fumi238pochi/status/2014324690660262080) 2026-01-22T13:10Z [---] followers, [--] engagements "$RVYL News: Nasdaq compliance; Roundtable merger; reverse split. Strengths: Digital payments; Web3 integration; Nasdaq listing. Surge: Merger expectations; 63.36% rise; high volume" [X Link](https://x.com/fumi238pochi/status/2014667205154394560) 2026-01-23T11:51Z [---] followers, [--] engagements "$REVB News: FDA Gemini AKI agreement; GMP manufacturing start; Q3 loss $1.9M; PRIME positive data. Strengths: Gemini immune platform; FDA path; cash to [----] Q3; strong buy rating. Rise: FDA news spillover; low float; biotech momentum" [X Link](https://x.com/fumi238pochi/status/2014670925506216445) 2026-01-23T12:05Z [---] followers, [---] engagements "$LWLG Strengths: Innovative low-power tech strong patents/team photonics market potential. Recent News: CEO as President; $35M funding; Form [---] sales. Today's Rise: +5.33% from financing strength AI momentum community buzz. $WFRD $MNTS $CNTX $ASST $TMDE $VRME $INBS $UFG" [X Link](https://x.com/fumi238pochi/status/2008195675864064511) 2026-01-05T15:15Z [---] followers, [---] engagements "$VALN Valneva SE is a specialty vaccine company focused on developing manufacturing and commercializing vaccines to prevent infectious diseases. The company currently offers three proprietary travel vaccines: IXIARO DUKORAL and IXCHIQ. #Stocks" [X Link](https://x.com/fumi238pochi/status/1973000683436830892) 2025-09-30T12:23Z [---] followers, [---] engagements "$FIX Q3 results beat expectations across the board: revenue +35% EPS doubled YoY $553M cash flow (+83% YoY); backlog signals sustained growth acquisition boosts direct revenue.$FIX Dividend up 20% to $0.60/share yield rises to 0.29% attracting income investors" [X Link](https://x.com/fumi238pochi/status/1981701774898778388) 2025-10-24T12:38Z [---] followers, [--] engagements "$JAMF Focusing on the AI+Security sector to upgrade its product line institutional attention continues to rise Major contract secured increasing penetration in the education market Short-term strong performance target price range $12.5$13.5 $ASAN $BL $ALKT $RNG $SEMR $SEMR" [X Link](https://x.com/fumi238pochi/status/1983488065348964575) 2025-10-29T10:56Z [---] followers, [---] engagements "$LMND Q3 [----] earnings beat: Rev $194.5M (+42% YoY +2.9% vs est $189M); adj. EPS -$0.51 (29% beat vs est -$0.73). FY25 rev guidance raised to $727-732M (beat est $713M). Strengthens AI underwriting efficiency narrative. Target: $69 $EGHT $SNDK $HCWC $RIGL $EVC $BW $KW $CHR" [X Link](https://x.com/fumi238pochi/status/1986082084222640370) 2025-11-05T14:44Z [---] followers, [---] engagements "$EOLS Q3 earnings beat (Nov [--] post-market) + momentum continuation. Key drivers: Sharp revenue growth raised guidance (beauty market recovery; Jeuveau: $63.2M). [----] growth + Evolysse product line expansion. Broad biotech sector rebound. Target : $18 $BIYA $FRGE $ALTO $SKYT" [X Link](https://x.com/fumi238pochi/status/1986430353045918063) 2025-11-06T13:47Z [---] followers, [---] engagements "focus on: $EXOD Crypto fintech; digital asset mgmt self-custody solutions. BTIG Buy rating $40 target (173% upside) after acquisition. Acquisition: W3C Corp Monavate Baanx for payments infra. Analyst Consensus: Strong Buy; avg 136% upside" [X Link](https://x.com/fumi238pochi/status/1994019640264032299) 2025-11-27T12:25Z [---] followers, [--] engagements "$TELA Target: $3.42 Q3 revenue up 9% to $20.7M loss narrowed $13M offering conference. OviTex for hernia repair natural healing [--] patents underserved markets. Q3 guidance optimism refinancing; up 11.3% to $1.28. #Stocks $DRCT $NFE $CNEY $PRPH $NVDA $TSLA $CRCL $INTC" [X Link](https://x.com/fumi238pochi/status/1995466536396497373) 2025-12-01T12:14Z [---] followers, [---] engagements "$COO Q4 revenue $1.065B (+5%); strategic review; analyst upgrades. Vision/women's health leader; 25% US lens share; myopia innovation. Today's Rise: Earnings beat drove 13% surge. Target Price:$85- $100 $GURE $SMX $WHLR $RSSL $TDIC $AKAN $GNPX $META $NVDA $TSLA $AXGN $INHD" [X Link](https://x.com/fumi238pochi/status/1996934261061177740) 2025-12-05T13:26Z [---] followers, [---] engagements "$VOR Vor Biopharma (VOR) eHSC platform for blood cancers autoimmune therapies. Gene-edited eHSC for safety/efficacy; telitacicept rights; solid IP/cash. JPMorgan Overweight $43 target; $100M offering; Zacks Buy. $XCUR $GIPR $ATMV $ALEX $NCPL $ATMC $TVGN $CIGL $SLXN $CNM $AMD" [X Link](https://x.com/fumi238pochi/status/1998338677425004846) 2025-12-09T10:27Z [---] followers, [---] engagements "$LGCY Target Price:$13.30 Q4 revenue +40.8%; CEO stock buy; rebound to $10.36. Healthcare education growth; Strong Buy rating; rising profits. Rise: Sector demand; Q4 results; analyst upgrades. $MSOX $YCBD $NX $TLRY $GRWG $MAPS $ACB $SNDL $MITK $FLGC $RGYY $MSOS $WEED $MJ" [X Link](https://x.com/fumi238pochi/status/1999462640956112986) 2025-12-12T12:53Z [---] followers, [---] engagements "$ARBB Arb IOT Group ($ARBB) IoT/AI solutions in agriculture & data centers AI server order ($45M) distributor deal; Nasdaq compliance issues resolved. End-to-end services AI innovation SE Asia focus; Moderate Buy rating $20 target. $META $AMCI $GLSI $KYTX $BDRX $HYFT $ASBP" [X Link](https://x.com/fumi238pochi/status/2000531413594980620) 2025-12-15T11:40Z [---] followers, [---] engagements "$CRON Cronos Group $CRON global cannabis cultivation & products. $67M European acquisition; Q3 revenue +6%; US rescheduling rumors. Debt-free $824M cash; brand innovation; Zacks Strong Buy. Today's Rise: +8-15% to $3.47; policy anticipation. $ARBB $ARTV $META $TSLA $NVDA" [X Link](https://x.com/fumi238pochi/status/2000539076928139580) 2025-12-15T12:10Z [---] followers, [---] engagements "$HHS Harte Hanks (HHS) customer experience in marketing care logistics. Q3 revenue $47.63M; credit extension; database acquisition; awards. Data-driven services; industry diversity; positive cash flow; key partnerships. Today's Rise:+5.96% ; revenue momentum partnerships" [X Link](https://x.com/fumi238pochi/status/2000567885052436882) 2025-12-15T14:05Z [---] followers, [--] engagements "$WYFI Target price: $25-53 Recent News: Q3 revenue +8% to $20.2M; net loss $15.75M. $865M Nscale deal; analysts positive. Strengths: AI infra integration; efficient retrofits; partnerships. Today's Rise: +20% on Nscale contract news. $PCAR $ALT $TSLA $NVDA $DJT $MU $AVGO $PLTR" [X Link](https://x.com/fumi238pochi/status/2001993899947008370) 2025-12-19T12:31Z [---] followers, [---] engagements "$TIVC Company: Tivic Health (TIVC) focuses on biotech for radiation syndrome treatments like Entolimod. Advantages: Innovative immunotherapy acquired manufacturing assets $90M+ funding. Recent News: Acquired Scorpius Holdings; Q3 [----] report highlights progress" [X Link](https://x.com/fumi238pochi/status/2003463722296283196) 2025-12-23T13:52Z [---] followers, [--] engagements "$RPGL Today's Surge: +176.91%+ on massive volume. Republic Power Group Limited (RPGL) - Singapore-based micro-cap ERP software provider for trade/logistics/property sectors. Customized ERP solutions regional focus (SG/MY) stable small-scale finances niche market edge" [X Link](https://x.com/fumi238pochi/status/2005687506747154529) 2025-12-29T17:09Z [---] followers, [--] engagements "$FONR News: FONAR signs privatization deal at $19/share 31.5% premium; closing Q3 [----]. Advantages: MRI pioneer; UPRIGHT MRI for positional scans better diagnostics. Rise: 25.7% surge today from deal announcement volume spike. $DRMA $MTEX $EKSO $GRI $BNRG $SIDU $NIO $SOPA" [X Link](https://x.com/fumi238pochi/status/2005981508570603609) 2025-12-30T12:37Z [---] followers, [---] engagements "$SGLY Stock rebound +22% since Dec [--] buy signal; penny stock scanner mentions; cash burn -86%. Logistics-digital assets integration tech efficiency cash optimization shipping market focus. Surge: +13.8% to $0.627 on momentum and speculation. $ULY $ANGH $MTEX $DRCT $ESHA" [X Link](https://x.com/fumi238pochi/status/2006352324223213575) 2025-12-31T13:10Z [---] followers, [---] engagements "$AEVA AEVA up 26.13% today on NVIDIA DRIVE Hyperion integration for [----] AV production. Recent news: NVIDIA partnership; exec stock sales. Advantages: FMCW 4D LiDAR for velocity detection AV robotics; multi-sector scalability. Targets: $24-26.50 $CYCN $ZETA $ANGO $BBDO $OS" [X Link](https://x.com/fumi238pochi/status/2008511014283997649) 2026-01-06T12:08Z [---] followers, [---] engagements "$ZETA up 10.52% today on OpenAI partnership for Athena AI marketing agent. Recent news: OpenAI integration; CES [----] AI event. Advantages: AI-driven Zeta Marketing Platform; real-time data insights; 6x ad ROI; scalable growth. Targets: $27-$29.67 $CYCN $BBDO $TSLA $NVDA $ONDS" [X Link](https://x.com/fumi238pochi/status/2008514307315953994) 2026-01-06T12:21Z [---] followers, [---] engagements "$RDW Recent News: $151B SHIELD contract; Edge Autonomy integration; European spacecraft win. Strengths: Space tech diversity; acquisitions; gov't ties; 50% Europe revenue. Today's Surge: SHIELD announcement drove 14%-27.46% stock rise to $13.98 amid defense optimism" [X Link](https://x.com/fumi238pochi/status/2016173364860031088) 2026-01-27T15:36Z [---] followers, [---] engagements "$BNZI Recent News: Q3 rev +163%; Superblocks acquisition; debt reduction. Strengths: AI marketing tools; high margins; ARR growth; analyst buy ratings. Surge: Analyst $23 target drove 17.57% rise to $1.31" [X Link](https://x.com/fumi238pochi/status/2016178645132304892) 2026-01-27T15:57Z [---] followers, [---] engagements "$MRNO News: Short interest up; stock up 222% from low; Bitcoin reserve plan. Strengths: Diverse Mexico hotels; tourism growth; recovery potential. Surge: Volume surge to 34M; short squeeze; market rally" [X Link](https://x.com/fumi238pochi/status/2016471033545363512) 2026-01-28T11:18Z [---] followers, [---] engagements "$LRN News: Q2 revenue +8%; enrollment +7.8%; outlook up. Strengths: Online ed leader; personalized K-12; career programs. Surge: Earnings beat; growth optimism; pre-market rally" [X Link](https://x.com/fumi238pochi/status/2016479179038937473) 2026-01-28T11:51Z [---] followers, [---] engagements "To anyone with a stock account: 🔥1:Follow us to get 5+ daily trading signals easy for beginners too; 🔥 2:Add our to get free 3-day top stock picks with 10%-300% return📈 Dont miss out if you want to grab stock market opportunities📈 https://wa.me/17162472886 https://wa.me/17162472886" [X Link](https://x.com/fumi238pochi/status/2016589856713920642) 2026-01-28T19:11Z [---] followers, [----] engagements "$VIAV Tech innovation partnerships (e.g. Rohde) market growth in defense/cyber. Q2 FY26 revenue +36% to $369M EPS +69%; restructuring saves $30M/year. Today's Rise (8.18%): Earnings beat upbeat Q3 guidance analyst upgrades $22" [X Link](https://x.com/fumi238pochi/status/2016839335438352429) 2026-01-29T11:42Z [---] followers, [---] engagements "$VIVS Recent News: Asia-Pacific distributor expansion (Jan [--] 2026); CSO appointment (Jan 6). Advantages: High-accuracy NAM models; early risk reduction; market growth in APAC. Surge Cause: Distributor deals drove 114.71%-146% after-hours rise to $3.65-$4.18" [X Link](https://x.com/fumi238pochi/status/2017199554903298277) 2026-01-30T11:33Z [---] followers, [---] engagements "$SNDK Company: SanDisk (SNDK) NAND flash storage leader for AI/data centers. Recent News: Q2 earnings beat (Jan 29); analyst upgrades (Jan 30). Advantages: High-density tech; AI demand; vertical integration. Surge Cause: Earnings surprise drove 20.52% pre-market rise to $650" [X Link](https://x.com/fumi238pochi/status/2017206002009985200) 2026-01-30T11:59Z [---] followers, [---] engagements "$LRHC Recent News: 25% cash burn cut; $79M [----] rev (+14%); 1:10 split Jan 26; $11M AI funding. Strengths: Diversified realty; 100% commissions; AI PropTech; 31% tech cost drop; AI pivot. Today's Rise: +39.8% to $4.18 pre-market; news momentum AI optimism" [X Link](https://x.com/fumi238pochi/status/2017250272054071597) 2026-01-30T14:55Z [---] followers, [---] engagements "Today The combinations of $FATBB $ELPW $PHOE $INLF $TCGL $VIVS and $YCBD performed exceptionally well today Exclusive trading details position sizing and hot topic predictions are shared daily via WhatsApp. Add: Join us Let's explore this together https://wa.me/17162472886 https://wa.me/17162472886" [X Link](https://x.com/fumi238pochi/status/2017343742265471069) 2026-01-30T21:06Z [---] followers, [---] engagements "$WWD Innovative aerospace/industrial controls global footprint diversified segments strong cash flow. Recent News: Q1 FY26 sales up 29% EPS beat; raised FY26 guidance; dividend increase. Today's Rise: Up 14.18% to $373.16 on earnings surprise and upbeat outlook" [X Link](https://x.com/fumi238pochi/status/2018708226565452113) 2026-02-03T15:28Z [---] followers, [---] engagements "The WhatsApp group has been created Today's recommended high-quality stocks will be shared in detail with buy and sell strategies in my WhatsApp group. Stock enthusiasts can add me on WhatsApp: 👇 👇 Reply "stocks" after adding to join. http://wa.me/16469226721 http://wa.me/16469226721" [X Link](https://x.com/fumi238pochi/status/2019420683722436824) 2026-02-05T14:39Z [---] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@fumi238pochi 🇺🇸Stock AnalystT+0🔥🔥🔥🇺🇸Stock AnalystT+0🔥🔥🔥 posts on X about strong, target, ai, acquisition the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Social category influence finance 43% stocks 38% technology brands 15% cryptocurrencies 14% exchanges 8% automotive brands 7% countries 2% agencies 2% currencies 1% travel destinations 1%
Social topic influence strong 27%, target 25%, ai 16%, acquisition 9%, beat 8%, products 7%, company 7%, nasdaq 7%, momentum 6%, dividend 6%
Top assets mentioned NVIDIA Corp. (NVDA) Tesla, Inc. (TSLA) Sandisk Corporation (SNDK) Micron Technology, Inc. (MU) Metadium (META) Sanofi (SNY) Engines of Fury (FURY) Sable Offshore Corp. (SOC) Sidus Space, Inc. (SIDU) Context Therapeutics Inc. (CNTX) Intel Corporation (INTC) Taiwan Semiconductor (TSM) Direct Digital Holdings, Inc. (DRCT) ARB IOT Group Limited (ARBB) Banco Bradesco S.A. American Depositary Shares (BBDO) ZetaChain (ZETA) Lumentum Holdings Inc. Common Stock (LITE) Ocular Therapeutix, Inc. (OCUL) Robinhood Markets, Inc. (HOOD) CCH Holdings Ltd (CCHH) Validity (VAL) Medtronic PLC (MDT) Anteris Technologies Global Corp. (AVR)
Top posts by engagements in the last [--] hours
"$LITE AI data center leader; photonics innovation; sold-out lasers; resilient operations. Q2 FY26 earnings beat; strong guidance; analyst upgrades/PT raises. Today's Rise: Up 8.45%; earnings momentum; AI demand; optimistic upgrades"
X Link 2026-02-06T13:51Z [---] followers, [---] engagements
"$OCUL Ocular Therapeutix (OCUL) eye disease biotech with sustained-release tech. Advantages: Patented platform; AXPAXLI pipeline; $345M cash to 2028; 58% growth forecast. Recent News: Sanofi rumors; trials; Q3 revenue $14.5M. Rise Cause: Up 21.32% on Sanofi acquisition buzz"
X Link 2026-01-15T11:51Z [---] followers, [---] engagements
"$HOOD Leading commission-free brokerage user-friendly app. Recent News: Q4 EPS est. $0.63 revenue +30%. Advantages: Diversified products crypto integration. Stock Rise: +6.32% on crypto rebound & market recovery"
X Link 2026-02-06T14:06Z [---] followers, [---] engagements
"$NBY Shift to digital assets; $134M funding; ATM issuance caused 54% drop; auditor change; shareholder meeting March [--]. Innovative eye/wound products; strong team; pivot potential; extended cash runway to [----]. Today's Rise: Speculative rebound from lows; oversold RSI"
X Link 2026-02-09T12:39Z [---] followers, [---] engagements
"$POWW Q3 earnings beat (EPS $0.01 revenue +7%); GunBroker integration; $15M buyback; SEC settlement. Leading gun marketplace; high margins (86.9%); strong cash ($69M); innovation in ammo/tech. Earnings surprise; operational gains; positive sentiment; potential 41% upside"
X Link 2026-02-09T12:44Z [---] followers, [---] engagements
"$BRLS Todays Surge: $BRLS up 100.61% with high volume breakout. Key Driver: Speculative rebound insider buying signals. Company Strengths: 45% sales growth expanding distribution premium brand awards. Outlook: watch financing updates. $UOKA $BRLS $CCHH $CCHH $VAL $EZRA"
X Link 2026-02-09T15:51Z [---] followers, [---] engagements
"🔥Consistent US stock profits 🔥Stop trading blind get direction + real-time strategies + key levels. 🔥Catch real opportunities. Avoid dumb losses. 🔥Click Join: 🔥Join our WhatsApp group Remove guesswork and trade profitably. http://wa.me/16469198509 http://wa.me/16469198509"
X Link 2026-02-09T23:53Z [---] followers, [---] engagements
"Today's recommended high-quality stocks will be shared in detail with buy and sell strategies in my WhatsApp group. Stock enthusiasts can add me on WhatsApp: 👇 👇 Reply "stocks" after adding to join. Don't miss any opportunity to grow your wealth. http://wa.me/16469198509 http://wa.me/16469198509"
X Link 2026-02-10T14:09Z [---] followers, [---] engagements
"$FURY Advantages: $20M cash Dolly Varden stake experienced board (Baker) Eau Claire NPV $554M sustainable ops. Jan 26: Appointed Baker; Jan 8: [----] review [----] drills. Jan [--] Rise (11.64%): Baker hire gold $5K/oz HC Wainwright $1.40 buy"
X Link 2026-01-29T12:28Z [---] followers, [---] engagements
"$TLF US leather craft retailer with stores and online sales. Strengths: Diverse products; strong cash flow; educational resources. News: $0.75/share special dividend; Q3 [----] earnings; asset sales. Rise Today: Dividend announcement boosted 16.52% pre-market to $3.35"
X Link 2026-02-04T12:33Z [---] followers, [---] engagements
"$AVR Company: Anteris Tech (AVR): Structural heart devices. Advantages: Innovative valves clinical data Medtronic ties. News: $20M offering; Medtronic $90M investment. Rise: Financing sparked 8.52% surge"
X Link 2026-01-21T13:02Z [---] followers, [---] engagements
"$LIMN Innovative CD47 antibodies for immuno-oncology GCC vaccine in Phase II strategic financing via equity and crypto. $30M equity MOU; digital asset investments. Today's Rise: Up 22.10% to $0.6973 on compliance speculation crypto strategies and momentum trading"
X Link 2026-02-03T15:16Z [---] followers, [---] engagements
"$LIMN surged 33.18% to $1.43 Congrats to those who bought $LIMN yesterday pocketed $1200-2800profit $LIMN Innovative CD47 antibodies for immuno-oncology GCC vaccine in Phase II strategic financing via equity and crypto. $30M equity MOU; digital asset investments. Today's Rise: Up 22.10% to $0.6973 on compliance speculation crypto strategies and momentum trading. https://t.co/xZ9R2LgKgL $LIMN Innovative CD47 antibodies for immuno-oncology GCC vaccine in Phase II strategic financing via equity and crypto. $30M equity MOU; digital asset investments. Today's Rise: Up 22.10% to $0.6973 on"
X Link 2026-02-04T17:32Z [---] followers, [---] engagements
"$GDTC News: Rejected misleading claims; MoU with UMMC; Acquired TC BioPharm tech; Chair stake up 21.95%. Strengths: Patented T cells; Strong pipeline; Clinical progress; Partnerships; Debt-free. Rise: Rebuttal drove 27.07% pre-market surge; High volume squeeze"
X Link 2026-02-05T13:19Z [---] followers, [---] engagements
"$ALGN News: Q4 revenue/EPS beat; Q1/FY guidance up; Swiss/Canadian initiatives. Strengths: Invisalign leader; AI/3D tech; Global dentists; High margins. Rise: Earnings/guidance drove 10.35% pre-market surge"
X Link 2026-02-05T13:35Z [---] followers, [---] engagements
"$PAHC surged after Q2 FY2026 earnings beat. EPS $0.87 vs $0.69 est.; revenue $373.9M vs $355.6M. Raised FY2026 EPS guidance to $2.93$3.10 (above $2.75 consensus). Driven by strong MFA portfolio 10.1% operating margin & positive animal health outlook"
X Link 2026-02-05T14:17Z [---] followers, [---] engagements
"$EHC Largest US inpatient rehab operator scale & innovation advantages. Q4 [----] Earnings: Revenue +10.5% to $1.54B EPS $1.46 (beat estimates). [----] Guidance: Revenue $6.37-6.47B EPS $5.81-6.10. Stock Rise: +18.54% due to strong results & outlook"
X Link 2026-02-06T13:29Z [---] followers, [---] engagements
"$ABP DiversImmune & MultiMab platforms for antibodies; leads ABP-102 (HER2/CD3) ABP-201 (VEGF/ANG-2). Celltrion partnerships; pipeline in immuno-oncology/ophthalmology. Strong IP in multispecifics for HER2+ cancers HCC gastric"
X Link 2026-02-10T12:55Z [---] followers, [---] engagements
"$CRDO Q3 FY2026 revenue $404-408M (beat guidance); FY2026 growth 200%; Needham Buy rating $220 target; new Blue Heron retimer launched. Today's Rise: Up 13.78% pre-market to $140 on earnings beat AI demand surge analyst upgrades; Q3 51.5% sequential growth fuels optimism"
X Link 2026-02-10T13:26Z [---] followers, [---] engagements
"$RENX Zimmer contract win debt restructure Nasdaq compliance notice equipment acquisitions. Sustainable waste-to-value tech licensing diversified eco-products financial growth. New Florida transport contract announcement pre-market surge 128.07%"
X Link 2026-02-11T12:27Z [---] followers, [---] engagements
"$NET Recent News: Q4 revenue $614.5M (up 34%) full-year $2.17B (up 33%) AI acquisitions analyst upgrades. Strengths: Global network zero-trust security CDN optimization AI integration revenue growth. Rise Cause: Strong Q4 earnings beat AI tailwinds; up 14.77%"
X Link 2026-02-11T12:38Z [---] followers, [---] engagements
"$LUXE Company: Global luxury group e-commerce retail via YNAP. Strengths: E-com scale unique experiences sales growth 5.7%. Recent News: Q2 sales 647M (tripled) EBITDA positive. Rise Today: +7.04% to $10.65 on JPM upgrade Q2 optimism"
X Link 2026-02-12T11:55Z [---] followers, [---] engagements
"$ATNI News: Sold towers for $297M; Q3 '25 EPS $0.18 beat; dividend. Strengths: Niche markets; fiber growth; $97M cash low debt. Rise Today: Tower sale drove 19.71% surge; debt reduction"
X Link 2026-02-12T13:04Z [---] followers, [---] engagements
"$MU Company: Semiconductor leader in DRAM NAND HBM for AI/data centers. Strengths: Tech lead in nodes 25% HBM share high margins 57-68%. Recent News: HBM4 early shipment; Q1 revenue $13.6B (+57%). Rise Today: +4.15% to $424.72 on HBM supply tightness AI demand"
X Link 2026-02-12T13:18Z [---] followers, [---] engagements
"$NRXP Recent News: Cleared $5.4M debt via equity Q3 report highlights NRX-101 progress FDA designations. Strengths: CNS focus on bipolar depression/PTSD; 70+ patents; HOPE subsidiary for clinics. Today's : Debt elimination boosts investor confidence stock up from $1.99 low"
X Link 2025-12-18T13:29Z [---] followers, [---] engagements
"$SOC Recent News: PHMSA pipeline interstate confirmation; Q3 savings; [----] Santa Ynez restart. Strengths: Offshore oil/gas; proven reserves 100+ wells; $17/bbl costs; expert team. Today's Rise: Regulatory fix ends CA hurdles; confidence surge; up 43-68% from $5.28"
X Link 2025-12-18T13:42Z [---] followers, [---] engagements
"$NBY Recent News: Special dividend $0.80/share; Zacks buy rating; CEO change; stock volatile. Strengths: Innovative eye/skin products; market penetration; strategic funding. Today's Rise: +30% on Zacks upgrade dividend reminder. $ORCL $CRWV $VLRS $SMX $BMRN $LUNR $BENF $LAZR"
X Link 2025-12-19T16:01Z [---] followers, [---] engagements
"$VMAR Recent News: $9.6M offering completed Dec 19; volatile stock 160% surge Dec 16; boat show promo. Strengths: Electric boat leader; zero-emission E-Motion tech; diverse models. Today's Rise: +29.4% on financing rebound short squeeze speculation. $HYMC $WKEY $THAR $MSN"
X Link 2025-12-22T10:54Z [---] followers, [---] engagements
"$THAR Recent:$1.85M compliance Sep 5; TH104 update Aug (+7%); $1.74M offering Jul; 240% surge Aug; CEO buy Dec [--]. Strengths:Immunology innovator; TH104 for itch; Minotaur partners; strong cash; FDA/EMA feedback. Today's:+12% on CEO buy clinical rebounds social buzz/squeeze"
X Link 2025-12-22T11:04Z [---] followers, [---] engagements
"$BMRA Strengths: GI diagnostics; innovative inFoods IBS test; cost-reducing solutions. Recent News: CMS $300 rate; Egypt auth; Q1 earnings; meeting approvals. Today's Surge: +5-10% on Medicare rate; boosts access; low float hype"
X Link 2025-12-23T14:13Z [---] followers, [--] engagements
"$METC Target Price: $34.50 Advantages: Premium met coal ops + rare earth/critical minerals transition (Brook Mine); strong liquidity from recent capital raises Today: Up 5.9% to $16.89 ; driven by $100M buyback announcement + technical rebound (double bottom RSI bullish)"
X Link 2025-12-24T10:46Z [---] followers, [--] engagements
"$INDP Target Price:$10.20-$10.50 Recent News: Lazar appointed co-CEO after stake buy; Q3 R&D costs down; Decoy20 clinical updates & $5.7M funding. Rise Reasons: Lazar's investment sparks 64% surge; low float amplifies volatility; positive sentiment on leadership. $MWG $DVAX"
X Link 2025-12-24T12:17Z [---] followers, [---] engagements
"$PATH Target Price: $19.00 Innovation leader (TIME Best 2025); network effects; FY25 rev $1.43B (+9%); 9% CAGR to [----]. Advantages: Joins S&P MidCap [---] Jan 2; insider sales; strong [----] performance. Recent News: S&P inclusion sparked 8.46% pre-market; long-term positive"
X Link 2025-12-24T13:28Z [---] followers, [--] engagements
"$SIDU Target price:$10-$20 Advantages: Full-stack space tech cost-effective solutions Florida hub defense contracts growth potential. Recent News: SHIELD program entry $25M public offering. Rise Cause: +30% on offering completion boosting finances. $IREN $BMNR $SOAR $FLYX"
X Link 2025-12-26T13:04Z [---] followers, [---] engagements
"$FLYX Target price:$4.67-$4.75 Advantages: Jet charters 20% Q3 revenue growth fleet efficiency aviation trends. Recent News: Volato FLYX dividend Mobile Service expansion Q3 earnings. Rise Cause: +5% on dividend record date momentum. $NCL $SOAR $CANF $SCNI $ATPC $SPRC"
X Link 2025-12-26T14:11Z [---] followers, [--] engagements
"$MEHA Strengths: Real revenue Amazon/Walmart sales new Kirkman beauty line. News: Strong Q3 new beauty launch post-IPO rebound. Todays Rise: Beauty momentum + seasonal demand + micro-cap speculation. Price: Rebound from $0.22 short-term target $0.50$1.00"
X Link 2025-12-26T15:25Z [---] followers, [---] engagements
"$VNDA Targets: $11.75-$14 Q3 sales up 18% to $56M; FDA lifts clinical hold Dec 4; Tradipitant positive data Nov 19; PDUFA for motion sickness Dec [--]. CNS-focused biopharma; key products Fanapt Hetlioz Ponvory; strong pipeline in rare diseases; solid cash for R&D"
X Link 2025-12-29T13:09Z [---] followers, [---] engagements
"$ESHA ESHA SPAC targets entertainment sports hospitality; merging with TOFF for health/fitness focus. Experienced team global network $5B+ value created. Recent News: Merger progress; deadline extended to Dec [----]. Today's Rise: +50.66% on merger optimism high volume"
X Link 2025-12-31T12:56Z [---] followers, [---] engagements
"$SOC High asset rights oil field growth potential $773M funding strong analyst buys (targets $19-33). Pipeline permit court denies injunction stock up 15% in Dec Roth MKM buy rating. Today's Rise:Legal win momentum analyst optimism technical rebound energy sector buzz"
X Link 2026-01-02T10:24Z [---] followers, [---] engagements
"$GWH Supports AI data centers with 22-hr storage scalability. Q3 [----] rev $214K net loss $10.38M; [--] MWh SRP project $40M raised. "Strong Buy" rating $3.50 target. Today's Rise: +7.98% to $2.03 on analyst optimism investor day sector momentum. $DVLT $ULY $CHOW $SLS"
X Link 2026-01-02T10:39Z [---] followers, [---] engagements
"$ORBS Holds 277M WLD 11K ETH $69M cash. $125M buyback announced. Volatile down 8% last week. Crypto/digital ID shift; 59% rev growth. Low P/S 0.8; institutional support. Infinity platform differentiates. 20.33% surge Jan [--]. Speculation buyback hype. Market sentiment shift"
X Link 2026-01-05T12:33Z [---] followers, [--] engagements
"$CNTX Strengths: Strong pipeline (CTIM-76 CT-95) no debt "strong buy" rating oncology focus. Recent News: CTIM-76 Phase [--] dosing; Q3 [----] updates; small-cap potential. Today's Rise: +22.58% from technical breakout healthcare momentum analyst optimism. Targets: $5.67"
X Link 2026-01-05T12:50Z [---] followers, [---] engagements
"$NCPL Targets: $2.25-$3.25 Recent News: Acquired Iverson Design AI assets (Jan [--] 2026); Q2 earnings call (Jan 7). Strengths: Scalable fintech platform for private funding; AI integration; positive financing. Today's Rise: Driven by AI acquisition; up 27% after-hours"
X Link 2026-01-07T11:17Z [---] followers, [--] engagements
"$GLUE Strengths: AI-driven molecular glue degraders diverse pipeline (oncology immunology) Novartis partnership. Recent News: MRT-8102 Phase [--] data (Jan 7): CRP down 85% IL-6 down 55%; Novartis deal (Sep 2025). Today's Rise: Positive Phase [--] results drove 53.15% surge"
X Link 2026-01-07T12:51Z [---] followers, [---] engagements
"$NGEN Targets: $7.85-$8.0 NervGen Pharma (TSXV: NGEN) biotech focused on neural repair via PTP tech. Innovative NVG-291 for SCI; strong clinical progress; diverse pipeline; solid financing. Recent News: Positive Phase 1b/2a data; $10M raise; SEC filing for NASDAQ uplist"
X Link 2026-01-08T10:56Z [---] followers, [----] engagements
"$SER Advantages: Non-immunogenic POZ tech; SER-252 for Parkinson's; partnerships (Enable); regulatory fast-track. Recent News: Enable's $30M Sanofi investment; FDA hold response; $20M financing. Today's Rise:Up 12.4% on partner funding hype and trial optimism. $NVVE $ELAB $ACON"
X Link 2026-01-08T12:18Z [---] followers, [---] engagements
"$OPAD Target Price: $2.30-$3.68 Company Advantages: Fast cash home offers cost efficiency tech-driven valuations. Recent News: Q3 earnings improvement new CMO exec stock grants. Today's Rise: +34.21% from Trump's $200B mortgage bond plan stimulating housing demand"
X Link 2026-01-09T13:13Z [---] followers, [--] engagements
"$LDI Target Price: $2.63-$3.55 Recent News: Trump $200B bond buy to cut rates; Q3 rev up amid policy volatility. Top non-bank lender with digital origination; diversified services ($116B+ value). Today's Surge: +14.34% pre-market on Trump plan boosting housing/loan demand"
X Link 2026-01-09T13:39Z [---] followers, [---] engagements
"$SGN Company: Signing Day Sports sports recruitment tech platform. Strengths: Digital ecosystem mergers (Swifty BlockchAIn) 45% retention. Recent News: Q2 revenue down 67% events merger progress. Today's Rise: +21.90% from market rally technical rebound high volume"
X Link 2026-01-12T12:37Z [---] followers, [--] engagements
"$PMAX News: Jan [--] shareholder meeting for capital restructure; Q3 [----] revenue down; Nasdaq compliance issues. Strengths: Niche compliance services integrated model Hong Kong hub advantage. Rise Today: Up 44.44% on restructure announcement high volume; speculative rebound"
X Link 2026-01-13T11:35Z [---] followers, [---] engagements
"$KELYA Recent News: Adopted poison pill for B-class shares sale ($1.06B); analyst target $17.67 (+95%). Strengths: Global staffing leader; diverse services; strong brand; low valuation growth. Today's Rise: Poison pill catalyst; technical breakout; +17.99% post-market"
X Link 2026-01-13T11:49Z [---] followers, [--] engagements
"$SAFX Recent News: Financing options explored; MOU with IP3 Southern for nuclear SAF; capacity doubling at Reno. Modular scalable SAF facilities; full-chain platform; IP licensing; ESG leadership. Today: Debt-to-equity conversion ($28M); BofA financing boost; volume surge"
X Link 2026-01-14T11:03Z [---] followers, [---] engagements
"$MREO Recent News: Target cuts (Needham $3); setrusumab analysis; alvelestat Phase 3; Phase [--] failure. Strengths: Rare disease focus; debt-free cash to 2027; partnerships; valuation appeal. Today's Rise: Update momentum; analyst buy; JPM event; volume surge. $MREO Company Advantages: Rare diseases pipeline efficient capital model debt-free with cash runway to [----]. Recent News: Phase [--] missed primary endpoint; Q3 loss; CEO at JPM conference. Stock Rise: Up 9.99% on Jan [--] from conference announcement. https://t.co/snq6KAAMF9 $MREO Company Advantages: Rare diseases pipeline efficient capital"
X Link 2026-01-14T11:18Z [---] followers, [---] engagements
"$NINE Recent News: Q3 [----] revenue $132M net loss $14.6M; Q4 forecast $122-132M. Advantages: ROCE 4.4%; intl revenue +19%; operational flexibility. Rise Cause: Up 13.48% amid oil price surge energy sector rally. $COIN $INTC $MSTR $FURY $DRTS $SEGG $IVP $ALTS $BARK $BNAI $NINE"
X Link 2026-01-14T15:47Z [---] followers, [---] engagements
"$RILY Company: BRC Group Holdings (RILY) diversified financial services. Advantages:Integrated banking/brokerage; mid-market expertise; flexible structure. Recent News:Q3 profit $91M; Nasdaq compliance; name change. Rise Cause: Up 38% on Q3 earnings beat delisting avoidance"
X Link 2026-01-15T11:35Z [---] followers, [---] engagements
"$BNKK Company: Bonk Inc. (BNKK) digital assets in BONK ecosystem. Advantages: revenue; Yerba brand; 100% growth forecast. Recent News: TenX partnership; Q1 $1.5M income; debt zero. Rise Cause: Up 49.64% on TenX BONK deal. $NVDA $TSM $TSLA $SNDK $CJMB http://BONK.fun http://BONK.fun"
X Link 2026-01-15T14:48Z [---] followers, [--] engagements
"$BYAH Recent News: Capital increase approval reverse split ticker change to BYAH. Strengths: Bio-skincare products restructuring for compliance low valuation. Today's Minor Uptick: Market factors post-restructuring sentiment penny volatility"
X Link 2026-01-16T12:01Z [---] followers, [--] engagements
"$SVRE Strengths:Anti-distraction system VRU detection partnerships (Cemex FedEx) patents TIME [----] Invention. Recent News:VisionWave LOI for RF defense US distribution deals 1:3 ADS split H1 [----] revenue up 57%. Today's Surge:+48.6% to $2.18 VisionWave deal 14.6M vol"
X Link 2026-01-16T12:11Z [---] followers, [---] engagements
"$SNDK Recent News: Analyst upgrades (450-580 targets) NVIDIA AI comments Q4 beat 52-week high. Strengths: NAND leader AI demand pricing power high EPS growth. Today's 5.21% Rise: Sector rally ( $TSM $MU) analyst optimism momentum"
X Link 2026-01-16T12:24Z [---] followers, [---] engagements
"$SHPH Company: Shuttle Pharma (SHPH): Cancer radiation sensitizers. Advantages: Innovative therapies AI discovery low valuation ($4M). News: acquisition; Phase [--] trials; funding. Rise: AI news drove 160.74% surge high volume. http://Molecule.ai http://Molecule.ai"
X Link 2026-01-20T14:08Z [---] followers, [--] engagements
"$RAPT Company: RAPT Therapeutics ( $RAPT): Immunology therapies for allergies. Advantages: Innovative antibodies clinical progress high potential. News: GSK $2.2B acquisition; Phase II trials. Rise: Acquisition news sparked 63.68% surge"
X Link 2026-01-20T14:14Z [---] followers, [--] engagements
"$UNG Company: UNG: ETF tracking natural gas futures. Advantages: Easy exposure high liquidity short-term trading. News: Futures rebound; weather LNG demand. Rise: Storm forecasts sparked 8%-20.14% surge"
X Link 2026-01-20T14:22Z [---] followers, [--] engagements
"$IMTE Strengths: Diverse: smart glass NFT platform halal cert; low-float. News: Nasdaq delist notices; filing delays. Surge: Low-float squeeze; compliance buzz; +64.03% pre-market"
X Link 2026-01-21T12:43Z [---] followers, [--] engagements
"$SXTP Recent News: 1:4 split Jan 20; Q3 sales +223%; Babesia study; ARAKODA growth. Company Strengths: FDA ARAKODA; innovation partners; clinical pipeline; "Strong Buy" $4.40 target. Today's Rise: +78% to $3.56 pre-market; split momentum; volume 247K; speculation"
X Link 2026-01-22T12:59Z [---] followers, [--] engagements
"$CUE Recent News: Insider buys; $10M offering; Q3 EPS beat; ImmunoScape deal; CUE-101 50% ORR. Company Strengths: Immuno-STAT; pipeline (CUE-101/102/401); partnerships; $5.10 target. Today's Rise: +7.64% to $0.4044 pre-market; biotech surge; high volume; speculation"
X Link 2026-01-22T13:10Z [---] followers, [--] engagements
"$RVYL News: Nasdaq compliance; Roundtable merger; reverse split. Strengths: Digital payments; Web3 integration; Nasdaq listing. Surge: Merger expectations; 63.36% rise; high volume"
X Link 2026-01-23T11:51Z [---] followers, [--] engagements
"$REVB News: FDA Gemini AKI agreement; GMP manufacturing start; Q3 loss $1.9M; PRIME positive data. Strengths: Gemini immune platform; FDA path; cash to [----] Q3; strong buy rating. Rise: FDA news spillover; low float; biotech momentum"
X Link 2026-01-23T12:05Z [---] followers, [---] engagements
"$LWLG Strengths: Innovative low-power tech strong patents/team photonics market potential. Recent News: CEO as President; $35M funding; Form [---] sales. Today's Rise: +5.33% from financing strength AI momentum community buzz. $WFRD $MNTS $CNTX $ASST $TMDE $VRME $INBS $UFG"
X Link 2026-01-05T15:15Z [---] followers, [---] engagements
"$VALN Valneva SE is a specialty vaccine company focused on developing manufacturing and commercializing vaccines to prevent infectious diseases. The company currently offers three proprietary travel vaccines: IXIARO DUKORAL and IXCHIQ. #Stocks"
X Link 2025-09-30T12:23Z [---] followers, [---] engagements
"$FIX Q3 results beat expectations across the board: revenue +35% EPS doubled YoY $553M cash flow (+83% YoY); backlog signals sustained growth acquisition boosts direct revenue.$FIX Dividend up 20% to $0.60/share yield rises to 0.29% attracting income investors"
X Link 2025-10-24T12:38Z [---] followers, [--] engagements
"$JAMF Focusing on the AI+Security sector to upgrade its product line institutional attention continues to rise Major contract secured increasing penetration in the education market Short-term strong performance target price range $12.5$13.5 $ASAN $BL $ALKT $RNG $SEMR $SEMR"
X Link 2025-10-29T10:56Z [---] followers, [---] engagements
"$LMND Q3 [----] earnings beat: Rev $194.5M (+42% YoY +2.9% vs est $189M); adj. EPS -$0.51 (29% beat vs est -$0.73). FY25 rev guidance raised to $727-732M (beat est $713M). Strengthens AI underwriting efficiency narrative. Target: $69 $EGHT $SNDK $HCWC $RIGL $EVC $BW $KW $CHR"
X Link 2025-11-05T14:44Z [---] followers, [---] engagements
"$EOLS Q3 earnings beat (Nov [--] post-market) + momentum continuation. Key drivers: Sharp revenue growth raised guidance (beauty market recovery; Jeuveau: $63.2M). [----] growth + Evolysse product line expansion. Broad biotech sector rebound. Target : $18 $BIYA $FRGE $ALTO $SKYT"
X Link 2025-11-06T13:47Z [---] followers, [---] engagements
"focus on: $EXOD Crypto fintech; digital asset mgmt self-custody solutions. BTIG Buy rating $40 target (173% upside) after acquisition. Acquisition: W3C Corp Monavate Baanx for payments infra. Analyst Consensus: Strong Buy; avg 136% upside"
X Link 2025-11-27T12:25Z [---] followers, [--] engagements
"$TELA Target: $3.42 Q3 revenue up 9% to $20.7M loss narrowed $13M offering conference. OviTex for hernia repair natural healing [--] patents underserved markets. Q3 guidance optimism refinancing; up 11.3% to $1.28. #Stocks $DRCT $NFE $CNEY $PRPH $NVDA $TSLA $CRCL $INTC"
X Link 2025-12-01T12:14Z [---] followers, [---] engagements
"$COO Q4 revenue $1.065B (+5%); strategic review; analyst upgrades. Vision/women's health leader; 25% US lens share; myopia innovation. Today's Rise: Earnings beat drove 13% surge. Target Price:$85- $100 $GURE $SMX $WHLR $RSSL $TDIC $AKAN $GNPX $META $NVDA $TSLA $AXGN $INHD"
X Link 2025-12-05T13:26Z [---] followers, [---] engagements
"$VOR Vor Biopharma (VOR) eHSC platform for blood cancers autoimmune therapies. Gene-edited eHSC for safety/efficacy; telitacicept rights; solid IP/cash. JPMorgan Overweight $43 target; $100M offering; Zacks Buy. $XCUR $GIPR $ATMV $ALEX $NCPL $ATMC $TVGN $CIGL $SLXN $CNM $AMD"
X Link 2025-12-09T10:27Z [---] followers, [---] engagements
"$LGCY Target Price:$13.30 Q4 revenue +40.8%; CEO stock buy; rebound to $10.36. Healthcare education growth; Strong Buy rating; rising profits. Rise: Sector demand; Q4 results; analyst upgrades. $MSOX $YCBD $NX $TLRY $GRWG $MAPS $ACB $SNDL $MITK $FLGC $RGYY $MSOS $WEED $MJ"
X Link 2025-12-12T12:53Z [---] followers, [---] engagements
"$ARBB Arb IOT Group ($ARBB) IoT/AI solutions in agriculture & data centers AI server order ($45M) distributor deal; Nasdaq compliance issues resolved. End-to-end services AI innovation SE Asia focus; Moderate Buy rating $20 target. $META $AMCI $GLSI $KYTX $BDRX $HYFT $ASBP"
X Link 2025-12-15T11:40Z [---] followers, [---] engagements
"$CRON Cronos Group $CRON global cannabis cultivation & products. $67M European acquisition; Q3 revenue +6%; US rescheduling rumors. Debt-free $824M cash; brand innovation; Zacks Strong Buy. Today's Rise: +8-15% to $3.47; policy anticipation. $ARBB $ARTV $META $TSLA $NVDA"
X Link 2025-12-15T12:10Z [---] followers, [---] engagements
"$HHS Harte Hanks (HHS) customer experience in marketing care logistics. Q3 revenue $47.63M; credit extension; database acquisition; awards. Data-driven services; industry diversity; positive cash flow; key partnerships. Today's Rise:+5.96% ; revenue momentum partnerships"
X Link 2025-12-15T14:05Z [---] followers, [--] engagements
"$WYFI Target price: $25-53 Recent News: Q3 revenue +8% to $20.2M; net loss $15.75M. $865M Nscale deal; analysts positive. Strengths: AI infra integration; efficient retrofits; partnerships. Today's Rise: +20% on Nscale contract news. $PCAR $ALT $TSLA $NVDA $DJT $MU $AVGO $PLTR"
X Link 2025-12-19T12:31Z [---] followers, [---] engagements
"$TIVC Company: Tivic Health (TIVC) focuses on biotech for radiation syndrome treatments like Entolimod. Advantages: Innovative immunotherapy acquired manufacturing assets $90M+ funding. Recent News: Acquired Scorpius Holdings; Q3 [----] report highlights progress"
X Link 2025-12-23T13:52Z [---] followers, [--] engagements
"$RPGL Today's Surge: +176.91%+ on massive volume. Republic Power Group Limited (RPGL) - Singapore-based micro-cap ERP software provider for trade/logistics/property sectors. Customized ERP solutions regional focus (SG/MY) stable small-scale finances niche market edge"
X Link 2025-12-29T17:09Z [---] followers, [--] engagements
"$FONR News: FONAR signs privatization deal at $19/share 31.5% premium; closing Q3 [----]. Advantages: MRI pioneer; UPRIGHT MRI for positional scans better diagnostics. Rise: 25.7% surge today from deal announcement volume spike. $DRMA $MTEX $EKSO $GRI $BNRG $SIDU $NIO $SOPA"
X Link 2025-12-30T12:37Z [---] followers, [---] engagements
"$SGLY Stock rebound +22% since Dec [--] buy signal; penny stock scanner mentions; cash burn -86%. Logistics-digital assets integration tech efficiency cash optimization shipping market focus. Surge: +13.8% to $0.627 on momentum and speculation. $ULY $ANGH $MTEX $DRCT $ESHA"
X Link 2025-12-31T13:10Z [---] followers, [---] engagements
"$AEVA AEVA up 26.13% today on NVIDIA DRIVE Hyperion integration for [----] AV production. Recent news: NVIDIA partnership; exec stock sales. Advantages: FMCW 4D LiDAR for velocity detection AV robotics; multi-sector scalability. Targets: $24-26.50 $CYCN $ZETA $ANGO $BBDO $OS"
X Link 2026-01-06T12:08Z [---] followers, [---] engagements
"$ZETA up 10.52% today on OpenAI partnership for Athena AI marketing agent. Recent news: OpenAI integration; CES [----] AI event. Advantages: AI-driven Zeta Marketing Platform; real-time data insights; 6x ad ROI; scalable growth. Targets: $27-$29.67 $CYCN $BBDO $TSLA $NVDA $ONDS"
X Link 2026-01-06T12:21Z [---] followers, [---] engagements
"$RDW Recent News: $151B SHIELD contract; Edge Autonomy integration; European spacecraft win. Strengths: Space tech diversity; acquisitions; gov't ties; 50% Europe revenue. Today's Surge: SHIELD announcement drove 14%-27.46% stock rise to $13.98 amid defense optimism"
X Link 2026-01-27T15:36Z [---] followers, [---] engagements
"$BNZI Recent News: Q3 rev +163%; Superblocks acquisition; debt reduction. Strengths: AI marketing tools; high margins; ARR growth; analyst buy ratings. Surge: Analyst $23 target drove 17.57% rise to $1.31"
X Link 2026-01-27T15:57Z [---] followers, [---] engagements
"$MRNO News: Short interest up; stock up 222% from low; Bitcoin reserve plan. Strengths: Diverse Mexico hotels; tourism growth; recovery potential. Surge: Volume surge to 34M; short squeeze; market rally"
X Link 2026-01-28T11:18Z [---] followers, [---] engagements
"$LRN News: Q2 revenue +8%; enrollment +7.8%; outlook up. Strengths: Online ed leader; personalized K-12; career programs. Surge: Earnings beat; growth optimism; pre-market rally"
X Link 2026-01-28T11:51Z [---] followers, [---] engagements
"To anyone with a stock account: 🔥1:Follow us to get 5+ daily trading signals easy for beginners too; 🔥 2:Add our to get free 3-day top stock picks with 10%-300% return📈 Dont miss out if you want to grab stock market opportunities📈 https://wa.me/17162472886 https://wa.me/17162472886"
X Link 2026-01-28T19:11Z [---] followers, [----] engagements
"$VIAV Tech innovation partnerships (e.g. Rohde) market growth in defense/cyber. Q2 FY26 revenue +36% to $369M EPS +69%; restructuring saves $30M/year. Today's Rise (8.18%): Earnings beat upbeat Q3 guidance analyst upgrades $22"
X Link 2026-01-29T11:42Z [---] followers, [---] engagements
"$VIVS Recent News: Asia-Pacific distributor expansion (Jan [--] 2026); CSO appointment (Jan 6). Advantages: High-accuracy NAM models; early risk reduction; market growth in APAC. Surge Cause: Distributor deals drove 114.71%-146% after-hours rise to $3.65-$4.18"
X Link 2026-01-30T11:33Z [---] followers, [---] engagements
"$SNDK Company: SanDisk (SNDK) NAND flash storage leader for AI/data centers. Recent News: Q2 earnings beat (Jan 29); analyst upgrades (Jan 30). Advantages: High-density tech; AI demand; vertical integration. Surge Cause: Earnings surprise drove 20.52% pre-market rise to $650"
X Link 2026-01-30T11:59Z [---] followers, [---] engagements
"$LRHC Recent News: 25% cash burn cut; $79M [----] rev (+14%); 1:10 split Jan 26; $11M AI funding. Strengths: Diversified realty; 100% commissions; AI PropTech; 31% tech cost drop; AI pivot. Today's Rise: +39.8% to $4.18 pre-market; news momentum AI optimism"
X Link 2026-01-30T14:55Z [---] followers, [---] engagements
"Today The combinations of $FATBB $ELPW $PHOE $INLF $TCGL $VIVS and $YCBD performed exceptionally well today Exclusive trading details position sizing and hot topic predictions are shared daily via WhatsApp. Add: Join us Let's explore this together https://wa.me/17162472886 https://wa.me/17162472886"
X Link 2026-01-30T21:06Z [---] followers, [---] engagements
"$WWD Innovative aerospace/industrial controls global footprint diversified segments strong cash flow. Recent News: Q1 FY26 sales up 29% EPS beat; raised FY26 guidance; dividend increase. Today's Rise: Up 14.18% to $373.16 on earnings surprise and upbeat outlook"
X Link 2026-02-03T15:28Z [---] followers, [---] engagements
"The WhatsApp group has been created Today's recommended high-quality stocks will be shared in detail with buy and sell strategies in my WhatsApp group. Stock enthusiasts can add me on WhatsApp: 👇 👇 Reply "stocks" after adding to join. http://wa.me/16469226721 http://wa.me/16469226721"
X Link 2026-02-05T14:39Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::fumi238pochi